Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
[primary effusion lymphoma]
Multicentric
Castleman
Disease
(
MCD
)
is
a
lymphoproliferative
disorder
presenting
with
heterogeneous
pathological
and
clinical
features
.
It
comprises
disease
entities
with
a
complex
aetiology
and
overlapping
pathogenesis
.
MCD
can
be
found
in
association
with
HIV
infection
,
plasma-cell
dyscrasias
,
Kaposi
sarcoma
(
KS
)
,
B-
cell
lymphomas
including
primary
effusion
lymphoma
(
PEL
)
and
its
solid
variant
,
and
Hodgkin
lymphoma
.
In
KSHV-associated
MCD
cases
,
a
common
association
is
KS
and
a
specific
variant
of
lymphoma
referred
to
as
"
plasmablastic
lymphoma
,
"
also
called
"
large
B-
cell
lymphoma
arising
in
KSHV-associated
MCD
"
lacking
EBV
infection
.
MCD
is
often
referred
to
as
human
interleukin-
6
(
hIL-
6
)
syndrome
,
since
an
overproduction
of
IL
-
6
occurs
in
MCD
-associated
diseases
as
well
as
in
MCD
itself
.
hIL-
6
and
a
viral
IL
-
6
(
vIL-
6
)
homolog
encoded
by
KSHV
can
independently
or
together
lead
to
flares
of
KSHV-associated
MCD
.
Recently
,
a
new
clinical
entity
was
proposed
to
describe
a
severe
systemic
infection
/
reactivation
of
KSHV
:
KSHV
inflammatory
syndrome
(
KICS
)
.
KICS
may
contribute
in
inducing
the
inflammatory
symptoms
seen
in
some
patients
with
severe
KS
or
PEL
.
The
precise
relationship
of
KICS
to
KSHV-associated
MCD
is
unclear
and
it
is
possible
that
KICS
may
be
prodromal
symptoms
to
frank
KSHV-associated
MCD
.
Options
for
treatment
of
KSHV-associated
MCD
and
related
diseases
include
monoclonal
antibodies
,
chemotherapy
,
immune
modulators
,
virus-activated
cytotoxic
therapy
and
antiviral
therapies
.
A
comprehensive
understanding
of
the
intricacies
of
the
HIV-KSHV
coinfection
will
probably
lead
to
additional
advances
in
therapy
and
managements
for
these
disorders
.
Diseases
Validation
Diseases presenting
"complex aetiology"
symptom
epidermolysis bullosa simplex
primary effusion lymphoma
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom